HealthSnap Secures $25M To Expand AI-Powered Virtual Care Platform
HealthSnapCompany
Eastward Capital PartnersInvestor
HealthSnap announced a $25 million growth‑stage financing round led by Eastward Capital Partners. The capital will fund expansion of its AI‑powered virtual‑care platform, product development, commercial growth and debt refinancing. The raise positions HealthSnap to broaden deployment across U.S. health systems and accelerate its AI‑driven care management offering.
HealthSnap secured $25 million in growth financing on August 6, 2026, with Eastward Capital Partners leading the round. The infusion will bolster the company’s balance sheet, fund product development, expand commercial and customer‑success initiatives, and refinance existing debt as it scales its AI‑enhanced virtual‑care platform nationwide.
Deal Terms
The round, classified as a growth‑stage venture round, was the sole disclosed transaction, with Eastward Capital Partners as the lead investor. No valuation or multiple was disclosed. Proceeds are earmarked for advancing the Advanced Primary Care Management solution, expanding the platform’s AI capabilities, and deepening enterprise adoption across leading U.S. health systems such as Prisma Health, AdventHealth, Ascension Health and Sentara Health.
Platform Growth
HealthSnap’s platform now integrates remote patient monitoring, chronic‑care management, advanced primary‑care management, analytics, reimbursement optimisation and care coordination into a single EMR‑integrated suite. It processes two patient measurements per second and has cut clinical alert frequency by 97% after a patient’s first year. The company supports more than 80,000 active patient programmes across 200 health systems and aims to exceed 100,000 programmes by year‑end.
CEO and co‑founder Samson Magid said the financing validates the long‑term vision of making continuous, intelligent healthcare the standard. He emphasized that AI is intended to augment, not replace, clinical teams. Over the past three years, HealthSnap’s revenue has grown more than fivefold, earning it a spot on the Inc. 5000 fastest‑growing list for 2025.
The capital will also expand HealthSnap’s AI specialist, engineering and product teams, positioning the firm to capture additional enterprise contracts and potentially explore international markets as AI‑driven virtual care gains traction across the broader healthcare ecosystem.
Why It Matters
The new capital gives HealthSnap a runway to deepen its AI integrations, which could sharpen its competitive edge against other virtual‑care SaaS providers such as Teladoc Health and Amwell. By reducing alert fatigue and automating enrollment and compliance outreach, HealthSnap can offer health systems higher clinician efficiency and lower operational costs—key differentiators in a market where hospitals are under pressure to improve outcomes while containing expenses.
For rivals, HealthSnap’s accelerated rollout may force a faster adoption of AI‑augmented workflows, prompting competitors to accelerate their own product roadmaps or seek strategic partnerships. Health systems that have already partnered with HealthSnap, like Prisma Health and AdventHealth, may gain early access to more sophisticated analytics and care‑coordination tools, potentially widening the gap with providers still using legacy telehealth solutions.
Key Points
- HealthSnap raised $25 million in a growth‑stage round led by Eastward Capital Partners.
- Funding will be used to expand the AI‑powered virtual‑care platform, commercial growth and refinance debt.
- The platform supports over 80,000 active patient programmes across 200 health systems.
- AI reduces clinical alert frequency by 97% after the first year of enrolment.
- Revenue has increased more than fivefold over the past three years, earning an Inc. 5000 listing in 2025.
Analysis
HealthSnap’s $25 million raise underscores the accelerating appetite for AI‑driven SaaS solutions in the healthcare sector. While the round’s valuation was undisclosed, the capital infusion suggests a confidence in the company’s ability to translate AI efficiencies into higher net revenue retention and expansion revenue for health‑system customers. By cutting alert fatigue by 97% and processing two measurements per second, HealthSnap can improve clinician productivity, a metric that directly impacts gross margin for provider partners. The funding will likely enable the firm to scale its Advanced Primary Care Management suite, targeting a broader set of enterprise contracts that could push its ARR multiple into the high‑single‑digit range, comparable to other high‑growth health‑tech SaaS players. For investors, the deal highlights a trend where growth‑stage capital is being allocated to platforms that combine AI with integrated care coordination, positioning them to capture a larger share of the $150 billion virtual‑care market. Operators should watch for increased pressure on legacy telehealth vendors to embed AI capabilities, while investors may see heightened M&A activity as larger health‑tech conglomerates look to acquire AI‑centric SaaS assets that can accelerate their own digital transformation roadmaps.